BR112016029864A2 - métodos e dispositivos para tratamento de desordens oculares posteriores. - Google Patents

métodos e dispositivos para tratamento de desordens oculares posteriores.

Info

Publication number
BR112016029864A2
BR112016029864A2 BR112016029864A BR112016029864A BR112016029864A2 BR 112016029864 A2 BR112016029864 A2 BR 112016029864A2 BR 112016029864 A BR112016029864 A BR 112016029864A BR 112016029864 A BR112016029864 A BR 112016029864A BR 112016029864 A2 BR112016029864 A2 BR 112016029864A2
Authority
BR
Brazil
Prior art keywords
methods
devices
ocular disorders
treating further
further ocular
Prior art date
Application number
BR112016029864A
Other languages
English (en)
Inventor
John Brooks Christopher
White Daniel
Noronha Glenn
Victor Andino Rafael
Patel Samirkumar
Original Assignee
Clearside Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clearside Biomedical Inc filed Critical Clearside Biomedical Inc
Publication of BR112016029864A2 publication Critical patent/BR112016029864A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
BR112016029864A 2014-06-17 2015-06-17 métodos e dispositivos para tratamento de desordens oculares posteriores. BR112016029864A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201462013209P 2014-06-17 2014-06-17
US201462018148P 2014-06-27 2014-06-27
US201462063792P 2014-10-14 2014-10-14
US201562155367P 2015-04-30 2015-04-30
US201562156802P 2015-05-04 2015-05-04
PCT/US2015/036299 WO2015195842A1 (en) 2014-06-17 2015-06-17 Methods and devices for treating posterior ocular disorders

Publications (1)

Publication Number Publication Date
BR112016029864A2 true BR112016029864A2 (pt) 2017-08-22

Family

ID=54936084

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016029864A BR112016029864A2 (pt) 2014-06-17 2015-06-17 métodos e dispositivos para tratamento de desordens oculares posteriores.

Country Status (12)

Country Link
US (1) US20180042765A1 (pt)
EP (1) EP3157463A4 (pt)
JP (2) JP6774340B2 (pt)
KR (1) KR102511477B1 (pt)
CN (1) CN107072765A (pt)
AU (1) AU2015277133A1 (pt)
BR (1) BR112016029864A2 (pt)
CA (1) CA2952822A1 (pt)
IL (1) IL249602A0 (pt)
MX (1) MX2016016836A (pt)
RU (1) RU2017101236A (pt)
WO (1) WO2015195842A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
CN104758118B (zh) 2010-10-15 2018-04-06 科尼尔赛德生物医学公司 用于进入眼睛的装置
CN104884049A (zh) 2012-11-08 2015-09-02 克莱尔塞德生物医学股份有限公司 用于在人类受试者中治疗眼部疾病的方法和装置
EP4378444A2 (en) 2013-05-03 2024-06-05 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
EP3003454B1 (en) 2013-06-03 2020-01-08 Clearside Biomedical, Inc. Apparatus for drug delivery using multiple reservoirs
PL3104814T3 (pl) 2014-02-12 2021-10-11 Gyroscope Therapeutics Limited Aparat do nadnaczyniówkowego podawania środka leczniczego
US9949874B2 (en) 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
US9925088B2 (en) 2014-06-06 2018-03-27 Janssen Biotech, Inc. Sub-retinal tangential needle catheter guide and introducer
JP2017524419A (ja) 2014-06-20 2017-08-31 クリアサイド バイオメディカル，インコーポレイテッド 薬剤送達のための挿入深さを制御するための可変径カニューレ及び方法
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
US10219936B2 (en) 2014-09-11 2019-03-05 Orbit Biomedical Limited Therapeutic agent delivery device with advanceable cannula and needle
US10258502B2 (en) 2014-09-18 2019-04-16 Orbit Biomedical Limited Therapeutic agent delivery device
SG11201805420SA (en) 2015-12-30 2018-07-30 Kodiak Sciences Inc Antibodies and conjugates thereof
BR112018013805A2 (pt) * 2016-01-08 2018-12-11 Clearside Biomedical, Inc. métodos e dispositivos para o tratamento de distúrbio ocular posterior com aflibercept e outros produtos biológicos
US10399713B2 (en) 2016-01-19 2019-09-03 Dr. Py Institute Llc Devices and methods for formulation processing
EP3413851B1 (en) 2016-02-10 2023-09-27 Clearside Biomedical, Inc. Packaging
US10478553B2 (en) 2016-03-09 2019-11-19 Orbit Biomedical Limited Apparatus for subretinal administration of therapeutic agent via a curved needle
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10806629B2 (en) 2016-06-17 2020-10-20 Gyroscope Therapeutics Limited Injection device for subretinal delivery of therapeutic agent
US11000410B2 (en) 2016-06-17 2021-05-11 Gyroscope Therapeutics Limited Guide apparatus for tangential entry into suprachoroidal space
US10646374B2 (en) 2016-06-17 2020-05-12 Orbit Biomedical Limited Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
US11076984B2 (en) 2017-03-13 2021-08-03 Gyroscope Therapeutics Limited Method of performing subretinal drainage and agent delivery
US20210060320A1 (en) * 2017-12-28 2021-03-04 Nichiban Co., Ltd. Transdermal drug delivery system and method for using same
US11724941B2 (en) 2018-02-15 2023-08-15 North Carolina State University Synthesis of micron and nanoscale carbon spheres and structures using hydrothemal carbonization
US20210046002A1 (en) * 2018-03-05 2021-02-18 Massachusetts Eye And Ear Infirmary Amelioration of autoimmune uveitis through blockade of csf1r
WO2019217678A1 (en) * 2018-05-09 2019-11-14 North Carolina State University Applicator for corneal therapeutics
US11039954B2 (en) * 2019-03-21 2021-06-22 Microoptx Inc. Implantable ocular drug delivery devices and methods
CN110009626A (zh) * 2019-04-11 2019-07-12 北京百度网讯科技有限公司 用于生成图像的方法和装置
CN114786731A (zh) 2019-10-10 2022-07-22 科达制药股份有限公司 治疗眼部病症的方法
WO2021168218A1 (en) * 2020-02-19 2021-08-26 Clearside Biomedical, Inc. Compositions comprising axitinib and methods of treating ocular disorders
WO2022120015A1 (en) * 2020-12-02 2022-06-09 Telios Pharma, Inc. Methods and compositions for treating an ophthalmic condition
JP2024500871A (ja) * 2020-12-17 2024-01-10 モビアス セラピューティクス， エルエルシー 注射装置および使用方法
CN113101502B (zh) * 2021-03-01 2023-01-17 李特 一种耳鼻喉科用治疗装置
CN113198003A (zh) * 2021-06-22 2021-08-03 万永年 一种用于皮肤损伤后预防萎缩性疤痕外用液及其制备方法
WO2023133455A1 (en) * 2022-01-06 2023-07-13 Clearside Biomedical, Inc. Compositions and methods for treating macular edema associated with uveitis
WO2024064848A2 (en) * 2022-09-23 2024-03-28 Inoculus Ventures, Inc. Dry eye treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2951938B1 (ja) * 1998-03-19 1999-09-20 日本ケミカルリサーチ株式会社 薬剤溶解機構を内蔵した注射器
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
AU2005209201B2 (en) * 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
WO2008070479A2 (en) * 2006-12-01 2008-06-12 Allergan, Inc. Method for determining optimum intraocular locations for drug delivery systems
US8083759B2 (en) * 2007-11-02 2011-12-27 Refocus Ocular, Inc. Apparatuses and methods for forming incisions in ocular tissue
US8221353B2 (en) * 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
PT2600930T (pt) * 2010-08-05 2021-03-22 Forsight Vision4 Inc Aparelho injetor e método para distribuição de fármacos
US20120101475A1 (en) * 2010-10-21 2012-04-26 Meridian Medical Technologies, Inc. High Efficiency Auto-Injector
EP2578260A1 (en) * 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
CN104884049A (zh) * 2012-11-08 2015-09-02 克莱尔塞德生物医学股份有限公司 用于在人类受试者中治疗眼部疾病的方法和装置
WO2015095772A2 (en) * 2013-12-20 2015-06-25 Emory University Formulations and methods for targeted ocular delivery of therapeutic agents

Also Published As

Publication number Publication date
JP6774340B2 (ja) 2020-10-21
JP2020063236A (ja) 2020-04-23
KR20170039128A (ko) 2017-04-10
US20180042765A1 (en) 2018-02-15
AU2015277133A1 (en) 2017-02-02
CA2952822A1 (en) 2015-12-23
JP2017524677A (ja) 2017-08-31
EP3157463A1 (en) 2017-04-26
KR102511477B1 (ko) 2023-03-16
MX2016016836A (es) 2017-07-27
WO2015195842A1 (en) 2015-12-23
RU2017101236A (ru) 2018-07-17
RU2017101236A3 (pt) 2019-05-16
CN107072765A (zh) 2017-08-18
EP3157463A4 (en) 2018-02-21
IL249602A0 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
BR112016029864A2 (pt) métodos e dispositivos para tratamento de desordens oculares posteriores.
IL283561B (en) Methods for treating eye diseases
BR112017007902A2 (pt) composições e métodos para o tratamento de distúrbios do sistema nervoso central.
HK1231417A1 (zh) 用於治療眼科疾病和障礙的化合物
EP3380121A4 (en) METHOD FOR THE TREATMENT OF EYE DISEASES
IL279308A (en) Methods for the treatment of heptidine-mediated disorders
BR112015002968A2 (pt) dispositivo para vestir e método para fabricar o mesmo
DK3139979T3 (da) Enhed, forstøver og fremgangsmåde
BR112016026939A2 (pt) aparelho e método.
BR112017011771A2 (pt) métodos e composições para o tratamento de câncer
BR112016021682A2 (pt) cenicriviroc para o tratamento da fibrose
BR112016016792A2 (pt) Aparelho para tratamento de vestuário
DK3231444T3 (da) Ny behandling
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
DK3393579T3 (da) Øjenbehandlingssystem
BR112016022976A2 (pt) Métodos para o tratamento de hcv
HUE049518T2 (hu) Készítmények és eljárások a szem megbetegedéseinek kezelésére és diagnosztizálására
ES2893126T8 (es) Métodos de tratamiento de afecciones oculares
BR112017002318A2 (pt) combinações de fármacos para tratar mieloma múltiplo.
BR112016029236A2 (pt) métodos para tratar prurido.
GB201620377D0 (en) Systems, methods, and kits for cleansing an ocular region
DK3209295T3 (da) Fremgangsmåder til behandling af øjenlidelser
IL252904A0 (en) Methods and factors for treating diseases
EP3302684A4 (en) METHOD AND DEVICES FOR TREATING THE CORNEA
ES1135015Y (es) Dispositivo para extraer mucosidad de las fosas nasales

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements